Mechanisms of decreased susceptibility to cefpodoxime in Escherichia coli

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 12, 2002, Pages 3829-3836

  Oliver, Antonio ^a,b,d   Weigel, Linda M ^b   Kamile Rasheed, J ^b   McGowan Jr , John E ^c   Raney, Patti ^b   Tenover, Fred C ^b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c EMORY UNIVERSITY   (United States)

^d HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; PENICILLIN DERIVATIVE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PORIN; TICARCILLIN; CEFTIZOXIME; DRUG DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DNA SEQUENCE; ESCHERICHIA COLI; GENE MUTATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; STAPHYLOCOCCUS AUREUS; BIOSYNTHESIS; DRUG EFFECT; ENZYMOLOGY; GENETICS; MICROBIOLOGICAL EXAMINATION; MULTIDRUG RESISTANCE;

BETA-LACTAMASES; CEFTIZOXIME; DRUG RESISTANCE, MULTIPLE; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; POLYMERASE CHAIN REACTION;

EID: 0036894206     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.12.3829-3836.2002     Document Type: Article

References (38)

1. Aggeler, R., R. Then, and R. Ghosh. 1987. Reduced expression of outermembrane proteins in β-lactam-resistant mutants of Enterobacter cloacae. J. Gen. Microbiol. 133:3383-3392.
2. Backman, A., P. Orvelid, J. A. Vazquez, O. Skold, and P. Olcen. 2000. Complete sequence of a β-lactamase-encoding plasmid in Neisseria meningitidis. Antimicrob. Agents Chemother. 44:210-212.
3. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
4. Caroff, N., E. Espaze, I. Berard, H. Richet, and A. Reynaud. 1999. Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyminocephalosporins without extended spectrum β-lactamase production. FEMS Microbiology Lett. 173:459-465.
5. Caroff, N., E. Espaze, D. Gautreau, H. Richet, and A. Reynaud. 2000. Analysis of the effects of -42 and -32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing AmpC. J. Antimicrob. Chemother. 45:783-788.
6. Centers for Disease Control and Prevention. 2000. Laboratory capacity to detect antimicrobial resistance, 1998. Morb. Mortal. Wkly. Rep. 48:1167-1171.
7. Chen, S. T., and R. C. Clowes. 1984. Two improved promoter sequences for the beta-lactamase expression arising from a single base-pair substitution. Nucleic Acids Res. 12:3219-3234.
8. Hall, M. N., and T. J. Silhavy. 1981. The ompB locus and the regulation of the major outer membrane porin proteins of Escherichia coli K12. J. Mol. Biol. 146:23-43.
9. Harder, K. J., H. Nikaido, and M. Matsuhashi. 1981. Mutant of Escherichia coli that are resistant to certain beta-lactam compounds lack the ompF porin. Antimicrob. Agents Chemother. 20:549-552.
10. Hernandez-Alles, S., V. J. Benedi; L. Martinez-Martinez, A. Pascual, A. Aguilar, J. M. Tomas, and S. Alberti. 1999. Development of resistance during antimicrobial therapy caused by insertion sequence interruption of porin genes. Antimicrob. Agents Chemother. 43:937-939.
11. Jaurin, B., T. Grundstrom, T. Edlund, and S. Normark. 1981. The E. coli β-lactamase attenuator mediates growth rate-dependent regulation. Nature 290:221-225.
12. Jaurin, B., T. Grundstrom, and S. Normark. 1982. Sequence elements determining ampC promoter strength in E. coli. EMBO J. 1:875-881.
13. TEM genes. Antimicrob. Agents Chemother. 44:2709-2714.
14. Livermore, D. M. 1995. β-lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557-584.
15. Martinez-Martinez, L., M. C. Conejo, A. Pascual, S. Hernandez-Alles, S. Ballesta, E. Ramirez de Arellano-Ramos, V. J. Benedi, and E. J. Perea. 2000. Activities of imipenem and cephalosporins against clonally related strains of Escherichia coli hyperproducing chromosomal β-lactamase and showing altered porin profiles. Antimicrob. Agents Chemother. 44:2534-2536.
16. Matthew, M., A. M. Harris, M. J. Marshall, and G. W. Ross. 1975. The use of analytical isoelectric focusing for detection and identification of β-lactamases. J. Gen. Microbiol. 88:169-178.
17. Mazzariol, A., G. Cornaglia, and H. Nikaido. 2000. Contributions of the AmpC β-lactamase and the AcrAB multidrug efflux system in intrinsic resistance of Escherichia coli K12 to β-lactams. Antimicrob. Agents Chemother. 44:1387-1390.
18. Medeiros, A. A., T. F. O'Brien, E. Y. Rosenberg, and H. Nikaido. 1987. Loss of ompC porin in a strain of Salmonella typhimurium causes increased resistance to cephalosporins during therapy. J. Infect. Dis. 156:751-757.
19. Murray, P. R., E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.). 1999. Manual of Clinical Microbiology, 7th Ed. American Society for Microbiology. Washington, D.C.
20. National Committee for Clinical Laboratory Standards. 2000. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. NCCLS Approved Standard M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
21. National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial susceptibility testing. NCCLS approved standard M100-S12. National Committee for Clinical Laboratory Standards, Wayne, Pa.
22. Nelson, E. C., and B. G. Elisha. 1999. Molecular basis of AmpC hyperproduction in clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 43:957-959.
23. Nikaido, H., and S. Normark. 1987. Sensitivity of Escherichia coli to various β-lactams is determined by the interplay of outer membrane permeability and the degradation by periplasmic β-lactamases: A quantitative predictive treatment. Mol. Microbiol. 1:29-35.
24. Oliver, A., Perez-Vazquez, M., M. Martinez-Ferrer, F. Baquero, L. de Rafael, and R. Canton. 1999. Ampicillin-sulbactam and amoxicillin-clavulanate susceptibility testing of Escherichia coli isolates with different β-lactam resistance phenotypes. Antimicrob. Agents Chemother. 43:862-867.
25. Olson, O., S. Bergstrom, F. P. Lindberg, and S. Normak. 1983. AmpC β-lactamase hyperproduction in Escherichia coli: Natural ampicillin resistance generated by horizontal chromosomal DNA transfer from Shigella. Proc. Natl. Acad. Sci. USA 80:7556-7560.
26. Ouellette, M., L. Bissonnette, and P. H. Roy. 1987. Precise insertion of antibiotic resistance determinants into Tn21-like transposons: Nucleotide sequence of the OXA-1 β-lactamase gene. Proc. Natl. Acad. Sci. USA 84:7378-7382.
27. Ozawa, Y., S. Mizushima, and T. Mizuno. 1990. Osmoregulatory expression of the ompC gene in Escherichia coli K-12; IS1 insertion in the upstream regulatory region results in constitutive activation of the promoter. FEMS Microbiol. Lett. 68:295-300.
28. Rasheed, J. K., C. Jay, B. Metchock, F. Berkowitz, L. Weigel, J. Crellin, C. Steward, B. Hill, A. A. Medeiros, and F. C. Tenover. 1997. Evolution of extended-spectrum β-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrob. Agents Chemother. 41:647-653.
29. Schumacher, H., U. Skibsted, R. Skov, and J. Scheibel. 1996. Cefuroxime resistance in Escherichia coli. APMIS 104:531-538.
30. Seoane, A. S., and S. B. Levy. 1995. Identification of new genes regulated by the marRAB operon in Escherichia coli. J. Bacteriol. 177:530-535.
31. Siu, L. K., J. Y. C. Lo, K. Y. Yuen, P. Y. Chau, M. H. NG, and P. L. Ho. 2000. β-lactamases in Shigella flexneri isolates from Hong Kong and Shanghai and a novel oxa-1 like β-lactamase, oxa-30. Antimicrob. Agents Chemother. 44:2034-2038.
32. Smith, P. K., R. L. Krohn, G. T. Hermanson, A. K. Mallia, F. H. Garter, M. D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olson, and D. C. Klenk. 1985. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:76-85.
33. Spratt, B. G., P. J. Hedge, S. te Heesen, A. Edelman, and J. K. Broome-Smith. 1986. Kanamycin-resistant vectors that are analogues of plasmids pUC8, pUC9, pEMBL8 and pEMBL9. Gene 41:337-342.
34. Stapleton, P., P. J. Wu, A. King, K. Shanon, G. French, and I. Phillips. 1995, Incidence and mechanism of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli. Antimicrob. Agents Chemother. 39:2478-2483.
35. Steward, C. D., J. K. Rasheed, S. K. Hubert, J. W. Biddle, P. M. Raney, G. J. Anderson, P. P. Williams, K. L. Brittain, A. Oliver, J. E. McGowan, Jr., and F. C. Tenover. 2001. Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum β-lactamase detection methods. J. Clin. Microbiol. 39:2864-2872.
36. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
37. Wu, P. J., K. Shanon, and I. Phillips. 1994. Effect of hyperproduction of TEM-1 β-lactamase on in vitro susceptibility of Escherichia coli to β-lactam antibiotics. Antimicrob. Agents Chemother. 38:494-498.
38. Yamamoto, T., M. Tanaka, F. Baba, and S. Yamagishi. 1981. Physical and functional mapping of Tn2603, a transposon encoding ampicillin, streptomycin, sulfonamide, and mercury resistance. Mol. Gen. Genet. 181:464-469.